Startup Insider cover image

Antibiotika-Entwicklung: 4,7 Mio. Pre-Series-A für smartbax – Dr. Robert Macsics

Startup Insider

00:00

KPIs, Meilensteine und Finanzierungsstrategie

Robert nennt präklinische Meilensteine, Mausmodelle, IND-Ziel und Exit-Optionen an Pharmapartner.

Play episode from 09:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app